- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01114984
Post-Breast Procedure Pain Syndrome Study
A Prospective Cohort Study to Evaluate the Incidence and Characteristics of Post-Operative Pain Among Patients Undergoing Various Breast Surgeries
Study Overview
Status
Conditions
Detailed Description
Post-operative breast pain is one of the most common adverse effects after breast surgery procedures. According to previous studies, anywhere from 20-60% of breast surgery patients report mastalgia as an adverse outcome of surgery (1, 2). Although the exact mechanism has not been well defined, the pain is generally neuropathic in nature and described as a burning sensation, electric and shock like, with a stabbing quality (2,3). The large majority of post-operative mastalgia is therefore believed to be secondary to nerve damage, particularly injury to the intercostobrachial nerve, and less commonly the long thoracic, medial and lateral pectoral, and/or the thoracodorsal nerves. Other reported causes of post-operative breast pain include scarring pain, lymphedema, radiation plexopathy, and hematomas (1-5).
Increasing rates of breast surgeries, whether elective, diagnostic, prophylactic, or therapeutic, warrant a more detailed examination of this pain-syndrome, particularly as previous research in the area is rather limited and narrow. A better understanding of the potential mechanisms causing pain, as well as more accurate and current incidence rates, and comparisons of adverse outcomes among the various options available to patients can help guide physicians towards improved clinical practices and patients towards more informed decision-making. Therefore, we designed this prospective cohort study to better understand the underlying mechanisms which may cause post-operative pain after various types of breast surgeries including breast biopsy, lumpectomy, mastectomy, mastectomy with reconstruction, cosmetic augmentation, and breast reduction, as well as to compare and contrast incidence, quality, and distribution of the post-operative pain caused by these various surgical procedures.
Study Type
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Cedars Sinai Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients scheduled to undergo one or more of the breast surgical procedures being studied for this project
- Willingness and ability to sign an informed consent document
- No allergies to anesthetic or analgesic medications
- Female,
- 18-80 years of age
- ASA class I-III adult
Exclusion Criteria:
- Patients with known allergy, hypersensitivity or contraindications to anesthetic or analgesic medications
- Patients with clinically-significant medical conditions, such as brain, heart, kidney, endocrine, or liver diseases, or history of chronic pain syndrome or neuropathy.
- Subjects with a history of alcohol or drug abuse within the past 3 months
- Subjects with a history of pain medication abuse
- Any other conditions or use of any medication which may interfere with the conduct of the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
10% after breast biopsy
Incidence Post-operative pain after breast surgery.
|
|
20% after lumpectomy
Incidence Post-operative pain after breast surgery
|
|
30% after simple mastectomy
Incidence Post-operative pain after breast surgery
|
|
50% after mastectomy with reconstruction
Incidence Post-operative pain after breast surgery
|
|
50% after radical mastectomy
Incidence Post-operative pain after breast surgery
|
|
50% after radi mastectomy+reconstruction
Incidence Post-operative pain after breast surgery after radical mastectomy with reconstruction
|
|
40% after cosmetic augmentation
Incidence Post-operative pain after breast surgery
|
|
40% after breast reduction
Incidence Post-operative pain after breast surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Pain using VRS
Time Frame: 6 months
|
prospective cohort evaluation of patients undergoing various breast surgery procedures, followed for a period of 6 months post-operatively, and assessed for post-operative breast pain.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Opioid consumption obtained from the recorded data
Time Frame: 6 months
|
Perioperative use of opioid consumption inside hospital (recorded by study staff and data obtained from patient charts) Post discharge use of opioid consumption (data obtained from the follow up questionnaires at 1, 2, or 3, then 7 days and at 6 months after surgery)
|
6 months
|
|
Postoperative nausea and vomiting using a Verbal Rating Scale
Time Frame: 6 months
|
Outcomes will be measured with follow up questionnaires at 1, 2, or 3, then 7 days and 6 months after surgery
|
6 months
|
|
Return to normal activities of daily living using follow up questionnaires
Time Frame: 6 months
|
Questionnaires will help evaluate patients recovery and return to normal activities of daily living(including dietary intake, bowel and bladder function, physical activities).
Patients will be contacted via mail or e-mail.
|
6 months
|
|
Patient satisfaction using a verbal rating scale from 0 to 100
Time Frame: 6 months
|
Patients will state their satisfaction level on a scale of 0= Not satisfied to 100= Excellent
|
6 months
|
|
Hospital stay
Time Frame: up to 1 week
|
Record number of days patients remain in hospital
|
up to 1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00019341
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.